Search

Your search keyword '"Diamond, Michael"' showing total 5,751 results

Search Constraints

Start Over You searched for: Author "Diamond, Michael" Remove constraint Author: "Diamond, Michael"
5,751 results on '"Diamond, Michael"'

Search Results

301. Comparing the simulated influence of biomass burning plumes on low-level clouds over the southeastern Atlantic under varying smoke conditions.

302. The impact of helminth-induced immunity on infection with bacteria or viruses.

305. Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination

306. Human Cardiac Pericytes Are Susceptible to SARS-CoV-2 Infection

307. Zika virus spreads through infection of lymph node-resident macrophages

308. Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants

310. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry

311. prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis

312. Immunogenicity and Tolerability of BBV154 (iNCOVACC®), an Intranasal SARS-CoV-2 Vaccine, Compared with Intramuscular Covaxin® in Healthy Adults: A Randomised, Open-Label, Phase 3 Clinical Trial

319. SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients

323. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects

324. The transposition of power: Law, lawyers, and social movements.

325. Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection

332. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

333. Zika virus infection damages the testes in mice

338. Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2

339. A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins

342. Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants

343. Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice

344. Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains

347. INCIDENCE OF PREGNANCY LOSS IN WOMEN UNDERGOING INFERTILITY TREATMENT

Catalog

Books, media, physical & digital resources